B-M cash gaffe: drugs client faces sanction
By Ian Hall, PR Week UK, 02 November 2006, 12:00am
A top drugs company is to be named and shamed for 'bringing discredit upon, and reducing confidence in' the pharma industry following a Burson-Marsteller blunder.
Share this story
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.









